Aurobindo Pharma Has on the list of broadest API portfolios between Indian pharmaceutical corporations, with above two hundred APIs. It is actually a number one global manufacturer of semi-synthetic penicillins and maintains a robust existence in anti-retrovirals and cardiovascular APIs. The corporate’s vertically integrated model gives substantial Value positive aspects. https://www.tjcy.com/industry-information/api-vs-fdf-vs-intermediates-what-s-the-difference.html